Castle Biosciences, Inc. - Common stock (CSTL)

Castle Biosciences Inc is a biotechnology company focused on developing and commercializing innovative diagnostic tests for skin cancer and other diseases

The company aims to enhance patient care by providing clinicians with critical information that can guide treatment decisions, ultimately improving patient outcomes. By leveraging proprietary technologies and a strong commitment to research and development, Castle Biosciences strives to make significant advancements in precision medicine and personalized healthcare. Their offerings include a range of tests designed to assess the likelihood of disease progression and response to treatment, catering to both patients and healthcare providers in the realm of oncology.